Skip to main content Skip to navigation

Dr Gareth Hall

Supervisor Details

Contact Details

Dr Gareth Hall

Department of Molecular and Cell Biology, University of Leicester

Research Interests

Structure-based drug discovery, design and development (SBD3) is a major translational research focus by my group, with successful, strategic research partnerships built with the research charity LifeArc. Through this close collaborations, my group aims to make a major contribution to the discovery, design and development of important new therapeutics, utilising structural biology (cryoEM, NMR spectroscopy and X-ray crystallography) to determine and characterise small molecule and antibody complex structures of proteins involved in key biological processes of significant medical importance. This research has made major contributions to translational programmes. For example, we have worked on ‘theranostic’ antibodies for both the diagnosis and treatment of HER2+ breast cancer and NSCLC, which are currently in Stage 2 clinical trials. Furthermore, my research includes the pioneering use of innovative new approaches to drug discovery, such as antibody-assisted structure-based drug discovery, which aims to identify and characterise novel regulatory or allosteric sites on target proteins, through the use of single chain antibodies, as well as the stabilisation of rare, functionally important conformational states of target proteins.

MIBTP Project Details

Primary supervisor for:

Co-supervisor on a project / projects with supervisor name + link.

Let us know you agree to cookies